Literature DB >> 20405534

UK places generic ban on mephedrone drug family.

Kelly Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20405534     DOI： 10.1016/s0140-6736(10)60559-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

2.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

3.  Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Dina M Francescutti; Katherine E Sykes; Mrudang M Shah; Abiy M Mohammed; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2012-02-09       Impact factor: 5.372

4.  Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Dina M Francescutti; Catherine E Sykes; Mrudang M Shah; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2013-01-08       Impact factor: 5.372

5.  Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Nieves Herrera-Mundo; Dina M Francescutti; Donald M Kuhn
Journal:  Life Sci       Date:  2013-07-24       Impact factor: 5.037

Review 6.  Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.

Authors:  Fabrizio Schifano; Antonio Albanese; Suzanne Fergus; Jackie L Stair; Paolo Deluca; Ornella Corazza; Zoe Davey; John Corkery; Holger Siemann; Norbert Scherbaum; Magi' Farre'; Marta Torrens; Zsolt Demetrovics; A Hamid Ghodse
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

7.  New non-randomised model to assess the prevalence of discriminating behaviour: a pilot study on mephedrone.

Authors:  Andrea Petróczi; Tamás Nepusz; Paul Cross; Helen Taft; Syeda Shah; Nawed Deshmukh; Jay Schaffer; Maryann Shane; Christiana Adesanwo; James Barker; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-08-03

8.  An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users.

Authors:  Lina Homman; Jessica Seglert; Michael J Morgan
Journal:  Psychopharmacology (Berl)       Date:  2018-06-26       Impact factor: 4.530

Review 9.  An updated review on synthetic cathinones.

Authors:  Jorge Soares; Vera Marisa Costa; Maria de Lourdes Bastos; Félix Carvalho; João Paulo Capela
Journal:  Arch Toxicol       Date:  2021-06-08       Impact factor: 5.153

10.  Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrine.

Authors:  Therese Bredholt; Elisabeth Ersvær; Bjarte Skoe Erikstein; André Sulen; Håkon Reikvam; Hans Jørgen Aarstad; Anne Christine Johannessen; Olav Karsten Vintermyr; Øystein Bruserud; Bjørn Tore Gjertsen
Journal:  BMC Pharmacol Toxicol       Date:  2013-07-11       Impact factor: 2.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.